Consensus Phreesia, Inc.

Stocks

PHR

US71944F1066

Software

Market Closed - NYSE 21:00:03 10/11/2026 GMT			5-day change	1st Jan Change
13.13 ^USD	+1.78%		+7.36%	-22.40%

10:16am	JPMorgan Downgrades Phreesia to Underweight From Neutral, $13 Price Target	MT
09-14	Phreesia, Inc. Announces Partnership with Deepintent, the Leading Healthcare Marketing Platform	CI

Evolution of the Average Target: Phreesia, Inc.

Evolution of the Target Price: Phreesia, Inc.

Changes in Analyst Recommendations: Phreesia, Inc.

a56d213193d727fffb.cdRBrYkH2jSL8SNYlNaB-cdZogB5Zd-tFcd13Wu2L7A.OeYb2cVfiAWml0Yc5O_lsrY6yW87KYeaX4wUsT7yZP03lxjf20GwZ7uTVA~61f0682d7782d39686561a53edb6f0c3

Analysts' recommendations: Phreesia, Inc.

10:16am	JPMorgan Downgrades Phreesia to Underweight From Neutral, $13 Price Target	MT
09-03	Phreesia's Catalyst for Q3 is Performance of Network Solutions Business, RBC Says	MT
05-29	Piper Sandler Downgrades Phreesia to Neutral From Overweight, Adjusts PT to $12 From $23	MT
05-28	Truist Adjusts Price Target on Phreesia to $12 From $11, Maintains Hold Rating	MT
05-20	Phreesia Shares Fall After Wells Fargo Downgrade	MT
05-20	Wells Fargo Downgrades Phreesia to Equalweight From Overweight, Adjusts Price Target to $9 From $15	MT
05-15	Barclays Downgrades Phreesia to Equalweight From Overweight, Adjusts Price Target to $10 From $24	MT
03-31	Top Midday Decliners	MT
03-31	JPMorgan Downgrades Phreesia to Neutral From Overweight, Adjusts Price Target to $16 From $24	MT
03-31	Citigroup Downgrades Phreesia to Neutral From Buy, Adjusts Price Target to $10 From $25	MT
03-31	Baird Downgrades Phreesia to Neutral From Outperform, Adjusts Price Target to $10 From $25	MT
03-31	Truist Downgrades Phreesia to Hold From Buy, Cuts Price Target to $11 From $24	MT
03-24	Mizuho Cuts Price Target on Phreesia to $19 From $22, Keeps Outperform Rating	MT
12-11	Truist Cuts Price Target on Phreesia to $29 From $36, Keeps Buy Rating	MT
11-13	BMO Capital Initiates Coverage on Phreesia With Outperform Rating, $32 Price Target	MT
05/09/25	Truist Lifts Price Target on Phreesia to $36 From $35, Keeps Buy Rating	MT
27/08/25	Mizuho Initiates Phreesia at Outperform With $36 Price Target	MT
29/05/25	Truist Lifts Price Target on Phreesia to $35 From $34, Keeps Buy Rating	MT
08/01/25	KeyBanc Raises Price Target on Phreesia to $30 From $28, Keeps Overweight Rating	MT
08/01/25	RBC Upgrades Phreesia to Outperform From Sector Perform, Raises Price Target to $32 From $24	MT
11/12/24	Truist Raises Price Target on Phreesia to $34 From $31, Keeps Buy Rating	MT
06/09/24	Truist Securities Adjusts Price Target on Phreesia to $31 From $29, Maintains Buy Rating	MT
11/07/24	KeyBanc Adjusts Price Target on Phreesia to $25 From $27, Maintains Overweight Rating	MT
03/06/24	Truist Securities Adjusts Price Target on Phreesia to $29 From $35, Maintains Buy Rating	MT
21/03/24	JMP Securities Raises Price Target on Phreesia to $30 From $28, Maintains Market Outperform Rating	MT

More recommendations

Other Software

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	PHREESIA, INC.					+6.12%
	MICROSOFT CORPORATION					+19.31%
	PALANTIR TECHNOLOGIES INC.					+31.65%
	ORACLE CORPORATION					+99.84%
	SAP SE					+15.91%
	PALO ALTO NETWORKS, INC.					+22.56%
	CROWDSTRIKE HOLDINGS, INC.					+10.6%
	APPLOVIN CORPORATION					+14.86%
	SERVICENOW, INC.					+56.43%
	ADOBE INC.					+12.76%
	Average					+29.00%
	Weighted average by Cap.					+25.35%